Nippon India Pharma Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8265 Cr | ₹837 Cr |
| Min Investment | ₹5000 | ₹1000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 10 Jul 2019 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 31% |
| Expense Ratio | 1.82 | 2.27 |
| Manager | Sailesh Raj Bhan | Dhaval Joshi |
| ISIN Code | INF204K01968 | INF209KB1N91 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Month | -1.59% | -0.56% |
| 6 Month | -4.59% | -2.4% |
| 1 Year | 0.68% | 0.86% |
| 3 Year | 21.11% | 21.2% |
| 5 Year | 14.17% | 12.74% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 6 Month | -3.06% | -2.56% |
| 1 Year | -1.02% | 0.95% |
| 3 Year | 13.13% | 13.47% |
| 5 Year | 14.66% | 14.2% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Year | 16.54% | 21.3% |
| 3 Year | 20.99% | 17.29% |
| 5 Year | 20.35% | 19.88% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.83% |
| Sharp | 1.01% | 0.95% |
| Beta | 0.87% | 0.93% |
| Alpha | 1.33% | 0.2% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Dhaval Joshi |
| Total AUM | ₹96086 Cr | ₹361932 Cr |
| Funds Managed | 5 | 55 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 3.47 | 3.13 |
| Mid Cap | 34.55 | 39.73 |
| Small Cap | 29.97 | 29.39 |
| Large Cap | 32.01 | 27.75 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 2.63 | 1.19 |
| Healthcare | 97.37 | 97.91 |
| Basic Materials | - | 0.9 |
Top Comparisons
Franklin India Conservative Hybrid Fund - Growth
3Y Returns9.08%
Franklin India Conservative Hybrid Fund - Growth
3Y Returns9.08%
360 ONE Focused Fund Regular-Growth
3Y Returns15.25%
DSP Focused Fund - Regular Plan - Growth
3Y Returns19.68%
BANDHAN CONSERVATIVE HYBRID FUND - Regular Plan - Growth
3Y Returns7.83%
Sundaram Conservative Hybrid Fund - Regular Plan - Growth
3Y Returns6.98%
Nippon India Banking & PSU Fund - Growth Plan - Growth Option
3Y Returns7.09%
Mirae Asset Banking and PSU Fund Regular Growth Plan
3Y Returns6.88%